Aerovate Therapeutics
AVTE
$20.57
Share price
-6.12%
Change (1 day)
7.30%
Change (1 year)
Categories
Aerovate Therapeutics (AVTE) - P/B ratio
P/B ratio as of May 2024 : 5.75
According to Aerovate Therapeutics's latest financial reports the company has a price-to-book ratio of 5.75.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aerovate Therapeutics - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.72 | 0.57% |
| 2022-12-31 | 5.69 | 240.77% |
| 2021-12-31 | 1.67 | |
| 2020-12-31 | N/A |